NCT00446550View on ClinicalTrials.gov

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 11, 2008

Primary Completion Date

August 20, 2009

Study Completion Date

August 20, 2009

Conditions
Gaucher DiseaseType 1 Gaucher DiseaseGaucher Disease, Type 1
Interventions
DRUG

afegostat tartrate

Trial Locations (11)

30033

Decatur

33065

Coral Springs

45229

Cincinnati

52242

Iowa City

66160

Kansas City

90211

Beverly Hills

02114

Boston

Unknown

Haifa

Tel Aviv

Johannesburg

London

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY